Enfortumab vedotin in the previously treated advanced head and neck cancer (HNC) cohort of EV-202

被引：0
|
作者：
Swiecicki, Paul
Yilmaz, Emrullah
Rosenberg, Ari J.
Fujisawa, Takao
Bruce, Justine Yang
Meng, Changting
Wozniak, Michele
Wang, Lu
Gorla, Seema Rao
Geiger, Jessica Lyn
机构：
[1] Univ Michigan, Sch Med, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI USA
[2] Cleveland Clin, Cleveland, OH USA
[3] Univ Chicago, Hematol Oncol Sect, Dept Med, Chicago, IL USA
[4] Natl Canc Ctr East Hosp, Dept Head & Neck Med Oncol, Translat Res Support Off, Chiba, Japan
[5] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[6] Seagen Inc, Bothell, WA USA
[7] Astellas Pharma US Inc, Northbrook, IL USA
[8] Astellas Pharma Inc, Northbrook, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6017
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Enfortumab vedotin (EV) in non-squamous and squamous non-small cell lung cancer (NSCLC) cohorts of EV-202
    Muro, Kei
    Feinstein, Trevor
    Baranda, Joaquina Celebre
    Bonta, Ioana
    Kitazono, Satoru
    Gersten, Todd A.
    Gandhi, Leena
    Kudo, Toshihiro
    Kaplan, Jason
    Gorla, Seema Rao
    Liu, Shubin
    Wozniak, Michele
    Lee, Anthony
    Patil, Tejas
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [12] Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
    Powles, Thomas
    Rosenberg, Jonathan E.
    Sonpavde, Guru P.
    Loriot, Yohann
    Duran, Ignacio
    Lee, Jae-Lyun
    Matsubara, Nobuaki
    Vulsteke, Christof
    Castellano, Daniel
    Wu, Chunzhang
    Campbell, Mary
    Matsangou, Maria
    Petrylak, Daniel P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1125 - 1135
  • [13] Enfortumab vedotin (EV) in triple-negative breast cancer (TNBC) and HR+/HER2-breast cancer (BC) cohorts of EV-202
    Giordano, Antonio
    Awan, Arif Ali Ali
    Bruce, Justine Yang
    Rugo, Hope S.
    Diamond, Jennifer Robinson
    Novik, Yelena
    Baranda, Joaquina Celebre
    Muro, Kei
    Ono, Makiko
    Nanda, Rita
    Kaplan, Jason
    Gorla, Seema Rao
    Liu, Shubin
    Wozniak, Michele
    Lee, Anthony
    Traina, Tiffany A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [14] Re: Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2022, 207 (01): : 228 - 228
  • [15] Cost-effectiveness of enfortumab vedotin in previously treated advanced urothelial carcinoma
    Wu, Qiuji
    Qin, Yi
    Liao, Weiting
    Zhang, Mengxi
    Yang, Yang
    Zhang, Pengfei
    Li, Qiu
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [16] EV-203: Phase 2 trial of enfortumab vedotin in patients with previously treated advanced urothelial carcinoma in China
    Li, Siming
    Shi, Yanxia
    Dong, Haiying
    Guo, Hongqian
    Li, Yue
    Kadeerbai, Haishan
    Xu, Chenming
    Kim, Eric
    Lee, Sue
    Gorla, Seema Rao
    Zhang, Jun
    Guo, Jun
    Sheng, Xinan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [17] Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer
    Hoimes, Christopher J.
    Flaig, Thomas W.
    Milowsky, Matthew, I
    Friedlander, Terence W.
    Bilen, Mehmet Asim
    Gupta, Shilpa
    Srinivas, Sandy
    Merchan, Jaime R.
    McKay, Rana R.
    Petrylak, Daniel P.
    Sasse, Carolyn
    Moreno, Blanca Homet
    Yu, Yao
    Carret, Anne-Sophie
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (01) : 22 - +
  • [18] Evaluating outcomes of sacituzumab govitecan (SG) in patients with urothelial cancer (UC), previously treated with enfortumab vedotin (EV)
    Vlachou, Evangelia
    Johnson, Burles Avner
    Hahn, Noah M.
    Rourke, Kelli
    Mcconkey, David James
    Hoffman-Censits, Jean H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 567 - 567
  • [19] EV-201: Results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and immune checkpoint inhibitors.
    Petrylak, Daniel Peter
    Balar, Arjun Vasant
    O'Donnell, Peter H.
    McGregor, Bradley Alexander
    Heath, Elisabeth I.
    Yu, Evan Y.
    Galsky, Matt D.
    Hahn, Noah M.
    Gartner, Elaina M.
    Pinelli, Juan
    Melhem-Bertrandt, Amal
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (18)
  • [20] EV-301: Phase Ill study to evaluate enfortumab vedotin (EV) versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial cancer (Ia/mUC).
    Petrylak, Daniel Peter
    Rosenberg, Jonathan E.
    Duran, Ignacio
    Loriot, Yohann
    Sonpavde, Guru
    Wu, Chunzhang
    Gartner, Elaina M.
    Melhem-Bertrandt, Amal
    Powles, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345